Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.
about
Prospects for vaccine prevention of meningococcal infectionBranhamella catarrhalis: epidemiology, surface antigenic structure, and immune responseThe tetrasaccharide L-alpha-D-heptose1-->2-L-alpha-D-heptose1--> 3-L-alpha-D-heptose1-->(3-deoxy-D-manno-octulosonic acid) and phosphate in lipid A define the conserved epitope in Haemophilus lipopolysaccharides recognized by a monoclonal antibodyModification of lipooligosaccharide with phosphoethanolamine by LptA in Neisseria meningitidis enhances meningococcal adhesion to human endothelial and epithelial cells.Update on meningococcal disease with emphasis on pathogenesis and clinical managementThe transcriptional repressor FarR is not involved in meningococcal fatty acid resistance mediated by the FarAB efflux pump and dependent on lipopolysaccharide structure.T-cell-stimulating protein A elicits immune responses during meningococcal carriage and human disease.Immunogenicity of outer membrane proteins in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: influence of adjuvants on the immune response.Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis.Differences in surface expression of NspA among Neisseria meningitidis group B strains.Neisseria meningitidis lipopolysaccharide modulates the specific humoral immune response to neisserial porins but has no effect on porin-induced upregulation of costimulatory ligand B7-2.Lipooligosaccharide structure contributes to multiple steps in the virulence of Neisseria meningitidis.Microheterogeneity of Neisseria lipooligosaccharide: analysis of a UDP-glucose 4-epimerase mutant of Neisseria meningitidis NMB.Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccineInner core biosynthesis of lipooligosaccharide (LOS) in Neisseria meningitidis serogroup B: identification and role in LOS assembly of the alpha1,2 N-acetylglucosamine transferase (RfaK).Two glycosyltransferase genes, lgtF and rfaK, constitute the lipooligosaccharide ice (inner core extension) biosynthesis operon of Neisseria meningitidis.Bacterial endosymbiont-derived lipopolysaccharides and a protein on symbiosome membranes in newly infected amoebae and their roles in lysosome-symbiosome fusion.Meningococcal group A lipooligosaccharides (LOS): preliminary structural studies and characterization of serotype-associated and conserved LOS epitopes.Improvement of immunogenicity of meningococcal lipooligosaccharide by coformulation with lipidated transferrin-binding protein B in liposomes: implications for vaccine development.Current status of meningococcal group B vaccine candidates: capsular or noncapsular?Tn916-generated, lipooligosaccharide mutants of Neisseria meningitidis and Neisseria gonorrhoeae.Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response.Vaccination with attenuated Neisseria meningitidis strains protects against challenge with live Meningococci.
P2860
Q24537338-17A9A0B1-DEBC-4B4B-96F6-6BE5F6AB4F26Q24650974-89AD6249-905F-4C65-889C-7DDB36D6401AQ28367729-BD32E7B0-EA63-4CEB-9373-51F1BEA73106Q33372688-77AA916F-50A9-4853-8C6C-D3C47BD7A70DQ33812435-A9FB751C-4FFE-4518-8818-D2A3385210B6Q33847702-3CCDC5FE-A254-4E41-9522-109CFA844AC6Q33946678-F2162FB8-80EE-43D5-9383-E3A282E7EA3BQ34001964-89145A05-846A-4142-9711-3F446D65D4D4Q34002209-11DBC9C0-4957-461E-850F-A55E3261DFECQ34002334-4EB4DBF7-AB55-4AAF-8BAB-4F660F6D450BQ34008652-1BB34185-5684-4C8E-AAB1-D7E02F1767A6Q34334420-8B8BB9A5-2D97-4759-80F9-6DE5FA0EEE0EQ35421789-D06DDFCD-88B1-4459-A672-F2EBABF7CB03Q35454550-FD868265-5908-4A35-B590-4CC5E14D0D49Q35603200-FC6DF9BD-59B8-43E5-8A2A-E36029C9868BQ35617191-F84702E7-881D-46CE-B79B-9542A06EC9C0Q35770932-3D41A098-337F-4547-8196-B9E08D11843DQ35778475-5501DF39-FE8B-4192-83F8-6F2A299E89BBQ35940728-D770CF0A-1B58-46B5-B5F0-D441C093AD11Q36642138-AA41CA1C-CFE0-453F-B017-7BAE316207AFQ36675071-EF76C271-CA99-46BC-BBB1-104ADE82F8C0Q37191328-B7CA8DC8-6811-4410-B70F-C19F87259CA5Q40582738-FAE21B8C-F738-4EF4-A1E3-7249EFADF0CE
P2860
Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1993
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.
@en
Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.
@nl
type
label
Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.
@en
Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.
@nl
prefLabel
Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.
@en
Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.
@nl
P2093
P2860
P1476
Meningococcal lipopolysaccharides: virulence factor and potential vaccine component
@en
P2093
P2860
P577
1993-03-01T00:00:00Z